Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular AMD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03699618
What this trial is testing

Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Submacular HemorrhageWet Macular DegenerationNeovascular Age-related Macular Degeneration
Johns Hopkins University 1
Not applicableWithdrawnNCT06398080
What this trial is testing

An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Wet Age-related Macular Degeneration (AMD)Diabetic Macular Edema (DME)+1 more
Regeneron Pharmaceuticals
Not applicableLooking for participantsNCT07434713
What this trial is testing

EarLy Treatment Response in nEoVascular Macular Degeneration With Eylea 8mg: ELEV8 A Prospective Observational Open Label Study Investigating the Fluid Dynamics During Early Response to Aflibercept 8mg in Patients With Exudative Age-related Macular Degeneration (AMD).

Who this might be right for
Age-Related Macular Degeneration (AMD)
Insel Gruppe AG, University Hospital Bern 50
Large-scale testing (Phase 3)Study completedNCT00764738
What this trial is testing

Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Retina Macula Institute 91
Not applicableEnded earlyNCT02510885
What this trial is testing

SD-OCT Angiography

Who this might be right for
Neovascular Age-related Macular DegenerationAge-related Macular DegenerationDiabetic Retinopathy+2 more
Duke University 39
Not applicableStudy completedNCT02251366
What this trial is testing

NVAMD Satellite Study

Who this might be right for
Neovascular Age Related Macular Degeneration
Johns Hopkins University 66
Large-scale testing (Phase 3)Study completedNCT05439629
What this trial is testing

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Bio-Thera Solutions 488
Not applicableEnded earlyNCT04764656
What this trial is testing

Observational Study to Evaluate Fluid Resolution and Effectiveness of Brolucizumab for nAMD in Portugal

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 81
Post-approval studies (Phase 4)Study completedNCT01988662
What this trial is testing

UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)

Who this might be right for
Neovacular Age-related Macular Degeneration
Novartis Pharmaceuticals 205
Testing effectiveness (Phase 2)Study completedNCT01485588
What this trial is testing

Safety and Tolerability Study for Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Iconic Therapeutics, Inc. 18
Large-scale testing (Phase 3)Study completedNCT04480463
What this trial is testing

Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Sam Chun Dang Pharm. Co. Ltd. 576
Testing effectiveness (Phase 2)Study completedNCT01678963
What this trial is testing

Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age Related Macular Degeneration
Ohr Pharmaceutical Inc. 142
Early research (Phase 1)Study completedNCT01997164
What this trial is testing

Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Regeneron Pharmaceuticals 20
Post-approval studies (Phase 4)Study completedNCT06591598
What this trial is testing

Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Who this might be right for
Diabetic Macular EdemaNeovascular Age-related Macular Degeneration
Bayer 51
Early research (Phase 1)Study completedNCT00536016
What this trial is testing

Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD

Who this might be right for
Macular Degeneration
Jerini Ophthalmic 36
Large-scale testing (Phase 3)Study completedNCT00095433
What this trial is testing

Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Genentech, Inc. 100
Large-scale testing (Phase 3)WithdrawnNCT02036723
What this trial is testing

Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Biocad
Not applicableStudy completedNCT06769412
What this trial is testing

A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg in the United States (US)

Who this might be right for
Retinal Vasculitis
Regeneron Pharmaceuticals 550,000
Large-scale testing (Phase 3)UnknownNCT02727881
What this trial is testing

Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD

Who this might be right for
Age-related Macular Degeneration
Ohr Pharmaceutical Inc. 230
Not applicableStudy completedNCT04659512
What this trial is testing

Recurrent Neovascular Age-related Macular Degeneration After Therapy Suspension

Who this might be right for
Age-related Macular Degeneration
St. Erik Eye Hospital 105
Next Page